Unraveling the role of guanylate-binding proteins (GBPs) in breast cancer: A comprehensive literature review and new data on prognosis in breast cancer subtypes
EN Hunt, JP Kopacz, DJ Vestal - Cancers, 2022 - mdpi.com
Simple Summary Interferons are important in normal breast development, but also in the
development and progression of breast cancers. Recently, three members of the Guanylate …
development and progression of breast cancers. Recently, three members of the Guanylate …
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway
W Zhang, X Tang, Y Peng, Y Xu… - … journal of oncology, 2024 - spandidos-publications.com
Chemoresistance is a major challenge in treating triple‑negative breast cancer (TNBC);
chemotherapy remains the primary approach. The present study aimed to elucidate the role …
chemotherapy remains the primary approach. The present study aimed to elucidate the role …
[HTML][HTML] A five-protein prognostic signature with GBP2 functioning in immune cell infiltration of clear cell renal cell carcinoma
K Meng, YY Li, DY Liu, LL Hu, YL Pan… - Computational and …, 2023 - Elsevier
Clear cell renal cell carcinoma (ccRCC) is of poor clinical outcomes, and currently lacks
reliable prognostic biomarkers. By analyzing the datasets of the Cancer Genome Atlas …
reliable prognostic biomarkers. By analyzing the datasets of the Cancer Genome Atlas …
Diagnosis and prognosis model for breast cancer based on DNAH10 which contributes to tumor immune infiltration and progression
L Wang, K Chen, W Wu, J Ding, Y Zhou, L Wan… - 2023 - researchsquare.com
Background Targeted therapy plays an important role in the treatment of breast cancer.
However, more biomarkers are still needed to distinguish breast cancer subgroups and …
However, more biomarkers are still needed to distinguish breast cancer subgroups and …